Lionheart Health to Showcase Regenerative Longevity Technology at Octane Medical Innovation Forum

Lionheart Health, Inc., operator of Lionheart Longevity & Wellness Clinics, will present its regenerative medicine technologies at the 2025 Octane Medical Innovation Forum focused on The Science of Longevity, scheduled for October 28-29, 2025 in Irvine, California. The forum, which brings together industry experts, entrepreneurs, investors and thought leaders for two days of learning and innovation, can be explored further at https://www.octane-oc.org/event/omif/agenda.

Executive Chairman and co-CEO Howard Leonhardt will showcase the company's first-in-class technology platform that utilizes precise patented bioelectric signaling sequences to trigger the release of regeneration-promoting proteins on demand. The technology controls expression of klotho, a protein identified as crucial for aging management, and regulates stem cell recruitment, proliferation and differentiation through patented signaling sequences.

The company's business model involves licensing its patented technology platform to clinics worldwide within exclusive territories. Currently operating one clinic in Newport Beach, California with seven additional licensed locations, Lionheart Health aims to establish 124 licensed sites within the next five years. This expansion strategy positions the company to potentially impact healthcare delivery models for longevity treatments globally.

Lionheart Health's technological achievements have garnered significant recognition, including being named a top 40 semi-finalist in the XPRIZE Healthspan Competition among 600 entries. The competition focuses on improving muscle health, brain health and immunity health with the goal of increasing healthy living years by 20 years. The company is now competing to advance as a top 10 finalist in this prestigious initiative.

Recent accolades include winning Medtech Outlook Magazine's Top Micro Stimulator Implant Development of 2025 award, being a finalist in the Orange County Business Journal's Innovator of the Year Award, and current finalist status in the Octane High Tech Awards' Medical Innovation category. The company previously received Abbvie Allergan's ULP Golden Passport Award in December 2023, recognizing innovation in medical aesthetics.

The company's most ambitious project involves developing a whole body regeneration chamber, described as a womb for adults. Current prototyping focuses on a version utilizing non-invasive technologies, with plans for a subsequent version incorporating advanced robotics, artificial intelligence, and implantable pump and stimulation technologies for internal organ regeneration. These developments are being pursued through partnerships with experts in each technical discipline.

Last month, Lionheart Health announced a partnership with Orange County-based CoreViva for AI-enhanced MRI diagnostics. The company maintains long-standing relationships with University Lab Partners and the UCI Beall Applied Innovation Center Prototyping Lab in Irvine, having won multiple UCI Capstone Grants for technologies including Brain Band, its bioelectric stimulation platform for brain health.

The presentation at the Octane Medical Innovation Forum represents a significant opportunity for Lionheart Health to demonstrate how bioelectric signaling technology could transform approaches to aging and regenerative medicine. The company's focus on both medical aesthetics and healthspan longevity positions it at the intersection of preventive healthcare and advanced medical technology, with potential implications for how society addresses aging-related health challenges.